ATE175212T1 - Cai-resistenzproteine kodierende dna, und ihre verwendung - Google Patents

Cai-resistenzproteine kodierende dna, und ihre verwendung

Info

Publication number
ATE175212T1
ATE175212T1 AT95914156T AT95914156T ATE175212T1 AT E175212 T1 ATE175212 T1 AT E175212T1 AT 95914156 T AT95914156 T AT 95914156T AT 95914156 T AT95914156 T AT 95914156T AT E175212 T1 ATE175212 T1 AT E175212T1
Authority
AT
Austria
Prior art keywords
dna encoding
cai
resistance proteins
cai resistance
functionally equivalent
Prior art date
Application number
AT95914156T
Other languages
English (en)
Inventor
Elise C Kohn
Lance A Liotta
Young Sook Kim
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE175212T1 publication Critical patent/ATE175212T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95914156T 1994-03-14 1995-03-14 Cai-resistenzproteine kodierende dna, und ihre verwendung ATE175212T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/212,190 US5652223A (en) 1994-03-14 1994-03-14 DNA encoding CAI resistance proteins and uses thereof

Publications (1)

Publication Number Publication Date
ATE175212T1 true ATE175212T1 (de) 1999-01-15

Family

ID=22789940

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95914156T ATE175212T1 (de) 1994-03-14 1995-03-14 Cai-resistenzproteine kodierende dna, und ihre verwendung

Country Status (11)

Country Link
US (2) US5652223A (de)
EP (1) EP0750637B1 (de)
JP (1) JPH09511236A (de)
AT (1) ATE175212T1 (de)
AU (1) AU684930B2 (de)
CA (1) CA2185341A1 (de)
DE (1) DE69507017T2 (de)
DK (1) DK0750637T3 (de)
ES (1) ES2128048T3 (de)
GR (1) GR3029811T3 (de)
WO (1) WO1995025125A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652223A (en) * 1994-03-14 1997-07-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services DNA encoding CAI resistance proteins and uses thereof
US6790936B1 (en) 1994-03-14 2004-09-14 The United States Of America As Represented By The Department Of Health And Human Services CAI resistance proteins and uses thereof
US6696558B2 (en) 1998-09-09 2004-02-24 The Burnham Institute Bag proteins and nucleic acid molecules encoding them
WO2000014106A1 (en) * 1998-09-09 2000-03-16 The Burnham Institute Novel bag proteins and nucleic acid molecules encoding them
US7320793B2 (en) * 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
EP1323733A1 (de) * 2001-12-28 2003-07-02 Arturo Leone BAG3-Nukleotid- und Proteinsequenzen zur Nutzung in Forschung, Diagnose und der Behandlung von Krankheiten, an denen Zelltod beteiligt ist
US7517697B2 (en) * 2003-02-05 2009-04-14 Applied Biosystems, Llc Compositions and methods for preserving RNA in biological samples
JP4785919B2 (ja) 2006-05-02 2011-10-05 学校法人帝京大学 グルタチオン増加物質のスクリーニング方法
EP2676966A1 (de) * 2012-06-19 2013-12-25 Biouniversa S.r.l. BAG3 als biochemisches Serum und Gewebemarker

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359078A (en) * 1989-05-19 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor compounds
US5652223A (en) * 1994-03-14 1997-07-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services DNA encoding CAI resistance proteins and uses thereof

Also Published As

Publication number Publication date
AU2126395A (en) 1995-10-03
AU684930B2 (en) 1998-01-08
DE69507017D1 (de) 1999-02-11
ES2128048T3 (es) 1999-05-01
DE69507017T2 (de) 1999-08-12
US5652223A (en) 1997-07-29
US5981712A (en) 1999-11-09
JPH09511236A (ja) 1997-11-11
GR3029811T3 (en) 1999-06-30
WO1995025125A1 (en) 1995-09-21
EP0750637B1 (de) 1998-12-30
EP0750637A1 (de) 1997-01-02
CA2185341A1 (en) 1995-09-21
DK0750637T3 (da) 1999-08-30

Similar Documents

Publication Publication Date Title
DE69635482D1 (de) Säugetieren apoptosis inhibitorprotein genfamilie, primers, probes und verfahren zur nachweis
DE122010000023I1 (de) IL-1 Rezeptor Fusionproteine verwendet als Antagoniste und Verfahren zu deren Verwendung und Hertstellung.
AU6380001A (en) Porous ferro- or ferrimagnetic glass particles for isolating molecules
ATE435280T1 (de) Methode zur isolierung von dna aus biologischen materialien
DE69834809D1 (de) Verfahren zur gewinnung von seltenen zellen aus blutprodukten
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
EP0188450A4 (de) Verfahren zum in vitro-nachweis und bestimmung unbekannter pathogene oder genetischer einheiten.
WO2003048300A3 (en) Methods of identifying cellular target molecules
PL374311A1 (en) Methods for purifying protein
DE69632466D1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DE60330841D1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
DE69434614D1 (de) Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
DK1157264T3 (da) Biokemiske oprensningsindretninger med immobiliserede opfangningsprober og anvendelser deraf
EP1135532A4 (de) Fluoreszierende proteine aus nicht-biolumineszenten arten der klasse anthozoa, gene die diese proteine kodieren und deren verwendungen
DE69507017D1 (de) Cai-resistenzproteine kodierende dna, und ihre verwendung
DE60117761D1 (de) Luciferase, fluoreszenzproteine, für luciferase und fluoreszenzproteine kodierend nukleinsaüre und ihre verwendung in der diagnose, hoch-durchsatz screeningsverfahren
BRPI0001536B8 (de)
EP0973794A4 (de) Netrinrezeptoren
DE69721551D1 (de) Proteom-analyse zum charakterisieren von auf- und abgeregelten proteinen in biologischen proben
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
SI1465927T1 (sl) Protitelesa proti BAG3 za uporabo pri raziskavi, diagnostiki in terapiji bolezni, ki vključujejo celično smrt
ATE166395T1 (de) Für c.difficile spezifische oligonukleotide
CA2273855A1 (en) Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
PT1127133E (pt) Polipeptido que proporciona permeabilidade celular
CA2331742A1 (en) Methods for quantitating low level modifications of nucleotide sequences

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee